A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Glioblastoma
In brief
The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM) participants treated with IGV-001 as compared with placebo.
Key facts
- Study ID
- NCT04485949
- Run by
- Imvax
- People needed
- 99
- Starts
- 2023-03-20
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-07-09
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- Henry Ford Health System — Detroit, Michigan, United States
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire, United States
- John Theurer Cancer Center At Hackensack UMC — Hackensack, New Jersey, United States
- Jersey Shore University Medical Center — Neptune City, New Jersey, United States
- Northwell Health at North Shore University Hospital — Manhasset, New York, United States
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- Columbia University Medical Center — New York, New York, United States
- Weill Cornell Medicine — New York, New York, United States
- Lenox Hill Hospital — New York, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
- Westchester Medical Center — Valhalla, New York, United States
- University of North Carolina (UNC) - Chapel Hill — Chapel Hill, North Carolina, United States
- UC Health — Cincinnati, Ohio, United States
- The Ohio State University (OSU) Wexner Medical Center — Columbus, Ohio, United States
- The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
- Thomas Jefferson University — Philadelphia, Pennsylvania, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- West Virginia University — Morgantown, West Virginia, United States
- University of Wisconsin - Madison — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.